(1)
Erny-Albrecht, K.; Erdmann, E. Cost-Effectiveness of Pioglitazone in Patients With Type 2 Diabetes and a History of Macrovascular Disease in a Swiss Setting. Swiss Med Wkly 2009, 139, 173-173.